Subthalamic stimulation in Parkinson disease: Intraoperative predictive factors

Archives of Neurology

Volumn 60, Issue 5, 2003, Pages 690-694

  Houeto, Jean Luc ^a   Welter, Marie Laure ^a   Bejjani, Paul Boulos ^c   Tezenas du Montcel, Sophie ^b   Bonnet, Anne Marie ^a   Mesnage, Valerie ^a   Navarro, Soledad ^b   Pidoux, Bernard ^b   Dormont, Didier ^b   Cornu, Philippe ^b   Agid, Yves ^a,b  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Notre Dame des Secours Hospital   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; DIATHERMY; DRUG DOSE REDUCTION; DYSKINESIA; ELECTRODE; ELECTROPHYSIOLOGY; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; NERVE CONDUCTION; PARKINSON DISEASE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

DISABILITY EVALUATION; DYSKINESIAS; ELECTRIC STIMULATION THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 0037651054     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.5.690     Document Type: Article

References (20)

1. Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 1998;339:1105-1111.
2. Kumar R, Lozano AM, Kim YJ, et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology. 1998;51: 850-855.
3. Moro E, Scerrati M, Romito LM, Roselli R, Tonali P, Albanese A. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology. 1999;53:85-90.
4. Houeto JL, Damier P, Bejjani PB, et al. Subthalamic stimulation in Parkinson disease: a multidisciplinary approach. Arch Neurol. 2000;57:461-465.
5. Molinuevo JL, Valldeoriola F, Tolosa E, et al. Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. Arch Neurol. 2000;57:983-988.
6. Volkmann J, Allert N, Voges J, Weiss PH, Freund HJ, Sturm V. Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology. 2001;56:548-551.
7. Welter ML, Houeto JL, Teznas du Montcel S, et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain. 2002;125:575-583.
8. Benabid AL, Benazzouz A, Hoffmann D, Limousin P, Krack P, Pollak P. Long-term electrical inhibition of deep brain targets in movement disorders. Mov Disord. 1998;13(suppl 3):119-125.
9. Bejjani BP, Dormont D, Pidoux B, et al. Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg. 2000;92:615-625.
10. Rodriguez-Oroz MC, Rodriguez M, Guridi J, et al. The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. Brain. 2001;124:1777-1790.
11. Fahn S, Elton RL, UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent Developments in Parkinson's Disease. Florham Park, NY: Macmillan Healthcare Information; 1987:153-163, 296-304.
12. Hutchison WD, Allan RJ, Opitz H, et al. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol 1998;44: 622-628.
13. Langston JW, Widner H, Goetz CG, et al. Core Assessment Program for Intracerebral Transplantations (CAPIT). Mov Disord. 1992;7:2-13.
14. Voges J, Volkmann J, Allert N, et al. Bilateral high-frequency stimulation in the subthalamic nucleus for the treatment of Parkinson disease: correlation of therapeutic effect with anatomical electrode position. J Neurosurg. 2002;96:269-279.
15. Bejjani BP, Damier P, Arnulf I, et al. Pallidal stimulation for Parkinson's disease: two targets? Neurology. 1997;49:1564-1569.
16. Caparros-Lefebvre D, Blond S, Feltin MP, Pollak P, Benabid AL. Improvement of levodopa induced dyskinesias by thalamic deep brain stimulation is related to slight variation in electrode placement: possible involvement of the centre median and parafascicularis complex. J Neurol Neurosurg Psychiatry. 1999;67: 308-314.
17. Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg. 1992;76:53-61.
18. Lhermitte F, Agid Y, Signoret JL. Onset and end-of-dose levodopa-induced dyskinesias: possible treatment by increasing the daily doses of levodopa. Arch Neurol. 1978;35:261-263.
19. Krack P, Pollak P, Limousin P, Benazzouz A, Deuschl G, Benabid AL. From offperiod dystonia to peak-dose chorea: the clinical spectrum of varying subthalamic nucleus activity. Brain. 1999;122(p16):1133-1146.
20. Benabid AL, Benazzouz A, Limousin P, et al. Dyskinesias and the subthalamic nucleus. Ann Neurol. 2000;47(suppl 1):S189-S192.